![](/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBHQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--e623d2450603cd9d4e6c86eae39da2c5b7f7bdd9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdERG9MY21WemFYcGxTU0lOTXpJd2VERTRNRjRHT2daRlZEb0pZM0p2Y0VraUVETXlNSGd4T0RBck1Dc3dCanNHVkRvTVozSmhkbWwwZVVraUMyTmxiblJsY2dZN0JsUTZESEYxWVd4cGRIbHBWVG9LYzNSeWFYQlVPZzVwYm5SbGNteGhZMlZKSWdsTWFXNWxCanNHVkRvTFpHVm1hVzVsU1NJZWFuQmxaenBtWVc1amVTMTFjSE5oYlhCc2FXNW5QVzltWmdZN0JsUT0iLCJleHAiOm51bGwsInB1ciI6InZhcmlhdGlvbiJ9fQ==--daee5f4cd191d67586af9b48495fbde7d4763d64/lucas-vasques-453684-unsplash.jpg)
Search
Filter Results
Displaying 31–40 of 1000 results
-
Jul 12, 2024
Eye on the Cure Podcast | Episode 69: Dr. Francois Paquet-Durand
Francois Paquet-Durand, PhD, a professor from the University of Tübingen and co-founder of the company Mireca, talks to host Ben Shaberman about the long journey of an emerging, Foundation-funded drug for the treatment of certain forms of retinitis pigmentosa. The episode highlights the challenges that scientists often encounter when developing a drug for a retinal disease, and the persistence and tenacity that are required to keep it moving forward.
-
VISIONS 2024 Session Recordings
VISIONS 2024, the global conference of the Foundation Fighting Blindness, provides an excellent opportunity to connect with others from the blind and low vision community and learn about the latest research advancements, products and services for members of our community.
-
Jul 11, 2024
Leber Congenital Amaurosis Research Advances
Recent developments in research on Leber congenital amaurosis
-
Jul 11, 2024
Age-Related Macular Degeneration Research Advances
Recent developments in research on age-related macular degeneration.
-
Jul 11, 2024
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmintosa.
-
Jul 11, 2024
Stargardt Disease Research Advances
Recent developments in research on Stargardt disease
-
Jul 11, 2024
Usher Syndrome Research Advances
Recent developments in research on Usher Syndrome.
-
Jul 8, 2024
Genentech to Re-Introduce Susvimo for Wet AMD
FDA-approved in 2021, the tiny implantable capsule provides sustained delivery of treatment, but was recalled in 2022.
-
Jul 8, 2024
Barry Smith and Emily Harding Smith
“I have spent a lifetime attempting to prove what I can do, which has allowed Emily and I to be in a place where we can help. Please consider joining us.“
-
Jul 8, 2024
A Vision of Hope and Light: Fai and Patrick’s Journey with the Foundation Fighting Blindness
“Legacy giving is about carrying the torch for future generations,” Fai shares. “It’s about ensuring that one day, we can all celebrate victories over vision loss together.”